Peptide Legal Status in Kansas
Standard federal compliance with typical state oversight. Kansas follows federal pharmaceutical guidelines with standard Board of Pharmacy regulation. No additional state-level peptide restrictions are imposed.
Key Facts
Regulatory Stance
moderate
Compounding Allowed
Yes
Age Restrictions
None
Kansas Regulatory Details
Kansas follows federal pharmaceutical guidelines with standard Board of Pharmacy regulation. No additional state-level peptide restrictions are imposed.
Peptide Availability in Kansas
| Peptide | FDA Status | Evidence | Availability |
|---|---|---|---|
| BPC-157 | Not Approved | C | Standard Access |
| TB-500 (Thymosin Beta-4) | Not Approved | C | Standard Access |
| GHK-Cu | Not Approved | B | Standard Access |
| Ipamorelin | Not Approved | B | Standard Access |
| CJC-1295 | Not Approved | B | Standard Access |
| Sermorelin | Approved | A | Available by Rx |
| Tesamorelin | Approved | A | Available by Rx |
| Bremelanotide (PT-141) | Approved | A | Available by Rx |
| Semaglutide | Approved | A | Available by Rx |
| Tirzepatide | Approved | A | Available by Rx |
| AOD-9604 | Not Approved | C | Standard Access |
| DSIP (Delta Sleep-Inducing Peptide) | Not Approved | D | Standard Access |
| Epithalon (Epitalon) | Not Approved | C | Standard Access |
| Selank | Not Approved | B | Standard Access |
| Semax | Not Approved | B | Standard Access |
| GHRP-2 | Not Approved | B | Standard Access |
| GHRP-6 | Not Approved | B | Standard Access |
| Hexarelin | Not Approved | B | Standard Access |
| Melanotan II | Not Approved | C | Standard Access |
| LL-37 | Not Approved | C | Standard Access |
| Thymalin | Not Approved | C | Standard Access |
| KPV | Not Approved | D | Standard Access |
| Liraglutide | Approved | A | Available by Rx |
| Retatrutide | Not Approved | B | Standard Access |
| Survodutide | Not Approved | B | Standard Access |
Peptides in Kansas: FAQ
Medical Disclaimer
This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations.
Always consult a qualified healthcare provider before starting, stopping, or modifying any treatment. Do not disregard professional medical advice based on information found on this site.
No claims of therapeutic efficacy are made for substances that are not FDA-approved for the discussed indications. Research citations reflect published findings and do not imply endorsement.